In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of The Goodyear Tire &
Rubber Company (NASDAQ:GT), Cars.com Inc. (NYSE:CARS), Tutor Perini
Corporation (NYSE:TPC), CVS Health Corporation (NYSE:CVS), VMware,
Inc. (NYSE:VMW), and Horizon Pharma Public Limited Company
(NASDAQ:HZNP), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
GT DOWNLOAD: http://Capital-Review.com/register/?so=GT
CARS DOWNLOAD: http://Capital-Review.com/register/?so=CARS TPC
DOWNLOAD: http://Capital-Review.com/register/?so=TPC CVS DOWNLOAD:
http://Capital-Review.com/register/?so=CVS VMW DOWNLOAD:
http://Capital-Review.com/register/?so=VMW HZNP DOWNLOAD:
http://Capital-Review.com/register/?so=HZNP
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine The
Goodyear Tire & Rubber Company (NASDAQ:GT), Cars.com Inc.
(NYSE:CARS), Tutor Perini Corporation (NYSE:TPC), CVS Health
Corporation (NYSE:CVS), VMware, Inc. (NYSE:VMW), and Horizon Pharma
Public Limited Company (NASDAQ:HZNP) on a fundamental level and
outlines the overall demand for their products and services in
addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts
from the recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed March 1st, 2019. Percentage calculations
are performed after rounding. All amounts in millions (MM), except
per share amounts.
-----------------------------------------
THE GOODYEAR TIRE & RUBBER COMPANY (GT) REPORT
OVERVIEW
The Goodyear Tire & Rubber's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, The Goodyear Tire & Rubber reported
revenue of $3,876.00MM vs $4,071.00MM (down 4.79%) and analysts
estimated basic earnings per share $0.46 vs -$0.37. For the twelve
months ended December 31st, 2018 vs December 31st, 2017, The
Goodyear Tire & Rubber reported revenue of $15,475.00MM vs
$15,377.00MM (up 0.64%) and analysts estimated basic earnings per
share $2.92 vs $1.39 (up 110.07%). Analysts expect earnings to be
released on April 24th, 2019. The report will be for the fiscal
period ending March 31st, 2019. The reported EPS for the same
quarter last year was $0.50. The estimated EPS forecast for the
next fiscal year is $2.94 and is expected to report on February
14th, 2020.
To read the full The Goodyear Tire & Rubber Company (GT)
report, download it here:
http://Capital-Review.com/register/?so=GT
-----------------------------------------
CARS.COM INC. (CARS) REPORT OVERVIEW
Cars' Recent Financial Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, Cars reported revenue of $169.31MM vs
$159.90MM (up 5.89%) and analysts estimated basic earnings per
share $0.23 vs $0.29 (down 20.69%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Cars reported revenue
of $626.26MM vs $633.11MM (down 1.08%) and analysts estimated basic
earnings per share $3.13 vs $2.46 (up 27.24%). Analysts expect
earnings to be released on May 8th, 2019. The report will be for
the fiscal period ending March 31st, 2019. Reported EPS for the
same quarter last year was $0.37. The estimated EPS forecast for
the next fiscal year is $2.64 and is expected to report on February
27th, 2020.
To read the full Cars.com Inc. (CARS) report, download it here:
http://Capital-Review.com/register/?so=CARS
-----------------------------------------
TUTOR PERINI CORPORATION (TPC) REPORT
OVERVIEW
Tutor Perini's Recent Financial Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, Tutor Perini reported revenue of
$1,123.14MM vs $1,199.51MM (down 6.37%) and analysts estimated
basic earnings per share $0.43 vs $0.47 (down 8.51%). For the
twelve months ended December 31st, 2017 vs December 31st, 2016,
Tutor Perini reported revenue of $4,757.21MM vs $4,973.08MM (down
4.34%) and analysts estimated basic earnings per share $2.99 vs
$1.95 (up 53.33%). Analysts expect earnings to be released on May
8th, 2019. The report will be for the fiscal period ending March
31st, 2019. Reported EPS for the same quarter last year was $0.01.
The estimated EPS forecast for the next fiscal year is $2.78 and is
expected to report on February 26th, 2020.
To read the full Tutor Perini Corporation (TPC) report, download
it here:
http://Capital-Review.com/register/?so=TPC
-----------------------------------------
CVS HEALTH CORPORATION (CVS) REPORT
OVERVIEW
CVS Health's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, CVS Health reported revenue of $54,424.00MM
vs $48,385.00MM (up 12.48%) and basic earnings per share -$0.37 vs
$3.22. For the twelve months ended December 31st, 2018 vs December
31st, 2017, CVS Health reported revenue of $194,579.00MM vs
$184,765.00MM (up 5.31%) and analysts estimated basic earnings per
share -$0.57 vs $6.47. Analysts expect earnings to be released on
May 1st, 2019. The report will be for the fiscal period ending
March 31st, 2019. The reported EPS for the same quarter last year
was $1.48. The estimated EPS forecast for the next fiscal year is
$7.70 and is expected to report on February 19th, 2020.
To read the full CVS Health Corporation (CVS) report, download
it here:
http://Capital-Review.com/register/?so=CVS
-----------------------------------------
VMWARE, INC. (VMW) REPORT OVERVIEW
VMware's Recent Financial Performance
For the three months ended October 31st, 2018 vs
October 31st, 2017, VMware reported revenue of $2,200.00MM vs
$1,938.00MM (up 13.52%) and analysts estimated basic earnings per
share $0.82 vs $0.97 (down 15.46%). Analysts expect earnings to be
released on May 30th, 2019. The report will be for the fiscal
period ending April 30th, 2019. The reported EPS for the same
quarter last year was $0.87. The estimated EPS forecast for the
next fiscal year is $5.73 and is expected to report on February
27th, 2020.
To read the full VMware, Inc. (VMW) report, download it here:
http://Capital-Review.com/register/?so=VMW
-----------------------------------------
HORIZON PHARMA PUBLIC LIMITED COMPANY (HZNP) REPORT
OVERVIEW
Horizon Pharma Public's Recent Financial
Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, Horizon Pharma Public reported revenue of
$325.31MM vs $271.65MM (up 19.76%) and analysts estimated basic
earnings per share $0.16 vs -$0.39. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Horizon Pharma Public
reported revenue of $1,056.23MM vs $981.12MM (up 7.66%) and
analysts estimated basic earnings per share -$2.52 vs -$1.04.
Analysts expect earnings to be released on May 8th, 2019. The
report will be for the fiscal period ending March 31st, 2019. The
reported EPS for the same quarter last year was $0.03. The
estimated EPS forecast for the next fiscal year is $1.99 and is
expected to report on February 26th, 2020.
To read the full Horizon Pharma Public Limited Company (HZNP)
report, download it here:
http://Capital-Review.com/register/?so=HZNP
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Nicole Garrens, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Cars com (NYSE:CARS)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Cars com (NYSE:CARS)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024